Objective:
To explore the hesitancy among ophthalmologists in recommending early surgical intervention for glaucoma and to advocate for minimally invasive procedures as a first-line treatment, emphasizing the need to address surgeon hesitancy.
Approach:
- 20% to 70% of glaucoma patients do not adhere to prescribed drop regimens, leading to disease progression.
- Minimally invasive glaucoma surgery (MIGS) offers effective IOP control with fewer complications compared to traditional methods.
- Selective laser trabeculoplasty (SLT) provides similar IOP-lowering benefits to drops without the associated side effects, highlighting its role in early intervention.
- Surgeon hesitancy remains a barrier to adopting MIGS as a standalone treatment, which can be mitigated through targeted education.
- Patient perceptions of surgery may still be influenced by misconceptions despite education, indicating a need for ongoing dialogue.
Key Findings:
Interpretation:
The shift from reliance on drops to early surgical intervention can enhance patient outcomes and reduce the burden on healthcare systems, necessitating a change in clinical practice.
Limitations:
Conclusion:
A proactive approach prioritizing surgical intervention can lead to better management of glaucoma and improved patient satisfaction, underscoring the urgency of adopting these practices.
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







